Institution · ALS Biopharma (United States)

Most cited papers from ALS Biopharma (United States)

ALS Biopharma (United States)

What are the most cited papers from ALS Biopharma (United States)?

The most cited paper from ALS Biopharma (United States) is "Considerations of Environmentally Relevant Test Conditions for Improved Evaluation of Ecological Hazards of Engineered Nanomaterials" (Patricia Ann Holden et al., 2016), with 235 citations. Next come "Fragile X protein mitigates TDP-43 toxicity by remodeling RNA granules and restoring translation" (97) and "The role of sulfamide derivatives in medicinal chemistry: a patent review (2006 – 2008)" (87).

Published FieldAccess

Showing 23 of 23 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Considerations of Environmentally Relevant Test Conditions for Improved Evaluation of Ecological Hazards of Engineered Nanomaterials Patricia Ann Holden et al. · Environmental Science & Technology Open access	13 May 2016	235
2	Fragile X protein mitigates TDP-43 toxicity by remodeling RNA granules and restoring translation Alyssa N. Coyne, Shizuka B. Yamada, Bhavani Bagevalu Siddegowda et al. · Human Molecular Genetics Open access	18 Sep 2015	97
3	The role of sulfamide derivatives in medicinal chemistry: a patent review (2006 – 2008) Allen B. Reitz, Garry R. Smith, Michael H. Parker · Expert Opinion on Therapeutic Patents	4 Aug 2009	87
4	Ubiquilin-2 (UBQLN2) binds with high affinity to the C-terminal region of TDP-43 and modulates TDP-43 levels in H4 cells: Characterization of inhibition by nucleic acids and 4-aminoquinolines Joel A. Cassel, Allen B. Reitz · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics Open access	27 Mar 2013	65
5	Novel inhibitors of heat shock protein Hsp70-mediated luciferase refolding that bind to DnaJ Joel A. Cassel, Sergey Olegovich Ilyin, Mark E. McDonnell et al. · Bioorganic & Medicinal Chemistry	12 Apr 2012	33
6	Characterization of a series of 4-aminoquinolines that stimulate caspase-7 mediated cleavage of TDP-43 and inhibit its function Joel A. Cassel, Mark E. McDonnell, Venkata Velvadapu et al. · Biochimie Open access	29 May 2012	32
7	An allosteric inhibitor of sirtuin 2 deacetylase activity exhibits broad-spectrum antiviral activity Kathryn L. Roche, Stacy Remiszewski, Matthew J. Todd et al. · Journal of Clinical Investigation Open access	14 Jun 2023	30
8	Nebulised budesonide using a novel device in patients with oral steroid-dependent asthma Claus Franz Vogelmeier, Péter Kardos, Thomas Hofmann et al. · European Respiratory Journal Open access	10 Dec 2014	28
9	Development of a Novel Nonradiometric Assay for Nucleic Acid Binding to TDP-43 Suitable for High-Throughput Screening Using AlphaScreen® Technology Joel A. Cassel, Benjamin E. Blass, Allen B. Reitz et al. · SLAS DISCOVERY Open access	21 Sep 2010	27
10	Synthesis, Stereochemical Analysis, and Derivatization of Myricanol Provide New Probes That Promote Autophagic Tau Clearance Mackenzie D. Martin, Laurent Calcul, Courtney Smith et al. · ACS Chemical Biology Open access	14 Jan 2015	24
11	Dipeptide Prodrugs of the Glutamate Modulator Riluzole Jeffrey C. Pelletier, Suzie Chen, Haiyan Bian et al. · ACS Medicinal Chemistry Letters Open access	15 Jun 2018	17
12	Structural basis for sirtuin 2 activity and modulation: Current state and opportunities Samuel P. Bernhard, Francesc X. Ruiz, Stacy Remiszewski et al. · Journal of Biological Chemistry Open access	22 May 2025	14
13	Qualitative Change in Migraine Prevention? Roger K. Cady, Richard B. Lipton · Headache The Journal of Head and Face Pain	Jul 2018	9
14	Current Nervous System Related Drug Targets for the Treatment of Amyotrophic Lateral Sclerosis Aaron C. Pawlyk, Joel A. Cassel, Allen B. Reitz · Current Pharmaceutical Design	13 May 2010	9
15	Differences in Exposure Between Intravenously (IV) Administered Eptinezumab and Subcutaneously (SC) Administered CGRP Inhibitor Monoclonal Antibodies After Single Therapeutic Doses (708) Brian Baker, Martin Béliveau, Susan M. Pederson et al. · Neurology	14 Apr 2020	3
16	Patient-Identified Most Bothersome Symptom in Patients with Chronic Migraine: An Analysis of PROMISE-2 (541) Richard B. Lipton, David W. Dodick, Jessica Ailani et al. · Neurology	14 Apr 2020	3
17	Proceedings of the second annual dengue endgame summit: A call to action Céline Hardy et al. · PLoS neglected tropical diseases Open access	28 Apr 2025	1
18	Eptinezumab Demonstrated Early and Sustained Reductions in HIT-6 Total and Item Scores Over Time in Patients with Chronic Migraine in the PROMISE-2 Trial (458) RJ Wirth, James S. McGinley, Carrie R. Houts et al. · Neurology	14 Apr 2020	1
19	Clinical Trial Schedule of Activities Specification Using Fast Healthcare Interoperability Resources Definitional Resources: Mixed Methods Study Andrew J. Richardson, Patrick Genyn · JMIR Medical Informatics Open access	16 Sep 2025	0
20	Correlation Analysis of the Change in SF-36 with Change in Patient-Identified Most Bothersome Symptom and Monthly Migraine Days (MMDs) in Patients with Chronic Migraine (CM): Results of the PROMISE-2 Study (519) William B. Young, Jessica Ailani, Dawn C. Buse et al. · Neurology	14 Apr 2020	0
21	Nano-hydroxyapatite Before the Science Court Frederick C. Klaessig · NanoEthics Open access	8 May 2023	0
22	Establishing Responder Definitions for Short-form Headache Impact Test (HIT-6) Total and Item Scores in Chronic Migraine (430) Carrie R. Houts, RJ Wirth, James S. McGinley et al. · Neurology	14 Apr 2020	0
23	Chemical conjugation of targeting peptide to ERT substantially improves binding for intended receptor and in vivo efficacy for clearing accumulated substrate in mouse models Hung Do, Russell R. Gotschall · Molecular Genetics and Metabolism	27 Jan 2014	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.